Celecoxib exerts protective effects in the vascular endothelium via COX-2-independent activation of AMPK-CREB-Nrf2 signalling

Although concern remains about the athero-thrombotic risk posed by cyclo-oxygenase (COX)-2-selective inhibitors, recent data implicates rofecoxib, while celecoxib appears equivalent to NSAIDs naproxen and ibuprofen. We investigated the hypothesis that celecoxib activates AMP kinase (AMPK) signalling...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Rashed, Fahad, Calay, Damien, Lang, Marie, Thornton, Clare C., Bauer, Andrea, Kiprianos, Allan, Haskard, Dorian O., Seneviratne, Anusha, Boyle, Joseph J., Schönthal, Alex H., Wheeler-Jones, Caroline P., Mason, Justin C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908847/
https://www.ncbi.nlm.nih.gov/pubmed/29674687
http://dx.doi.org/10.1038/s41598-018-24548-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908847/
https://www.ncbi.nlm.nih.gov/pubmed/29674687
http://dx.doi.org/10.1038/s41598-018-24548-z

Ejemplares similares